Assistance Listing 93.494
Global Tuberculosis:Developing,Evaluating,Implementing Evidence-based and Innovative Approaches to Find, Cure, and Prevent Tuberculosis Globally
Department of Health and Human Services · Centers for Disease Control and Prevention
Assistance Listing 93.494, “Global Tuberculosis:Developing,Evaluating,Implementing Evidence-based and Innovative Approaches to Find, Cure, and Prevent Tuberculosis Globally,” is a federal program administered by Department of Health and Human Services. It provides cooperative agreement assistance. GrantsJunction currently tracks 0 open, 0 forecasted and 1 closed opportunities under this listing. The agency reported $5.08M in obligations for fiscal year 2025.
Program objective
CDC’s global health priorities include efforts towards ending the global tuberculosis (TB) epidemic by: expanding access to improved screening, contact tracing, and diagnostic tools to find the missing TB cases (FIND); optimizing treatment for TB and multi-drug-resistant (MDR) TB, including identifying and evaluating better treatment regimens, and expanding access to care and treatment (CURE); breaking the cycle of TB transmission by strengthening infection control, identifying TB hotspots to target screening, and scaling-up treatment to prevent TB (PREVENT); and helping countries strengthen their surveillance and laboratory systems, and workforce and research capacity to support sustainable health systems including promoting the wider use and adoption of recommended TB strategies and guidelines (SUSTAIN).
As published in the SAM.gov Assistance Listing.
Current opportunities under 93.494
No open or forecasted opportunities are currently posted under this listing. Programs often post notices on an annual cycle — see recently closed opportunities below for timing.
Eligible applicants (program level)
- Unrestricted by Entity Type
Competition is open, limited, or single eligibility by authorizing legislation.
Intended beneficiaries: Minority group, Artist/Humanist, Scientist/Researchers, Graduate Student, Student/Trainee, Education Professional, Health Professional, Anyone/general public, Other private institution/organization, Quasi-public nonprofit organization and 11 more.
Program-level eligibility from SAM.gov. Each funding notice sets its own requirements.
Reported obligations by fiscal year
Historical data · not a predictionRange and average of financial assistance (from the listing): Awards may range from $700,000 to $3,500,000. Average award is expected at $2,491,622.
Source: SAM.gov Assistance Listing 93.494. Hatched bars are agency estimates. These totals do not indicate approval rates.Recently closed under 93.494
| Opportunity | Status | Award range | Closes | ALN |
|---|---|---|---|---|
Ending HIV and TB as public health threats through an accelerated and sustained comprehensive response in IndiaCenters for Disease Control-GHC | Closed | Amount not specified | Sep 16, 2026 | 93.067, 93.494 |
Frequently asked questions
What is ALN 93.494?
93.494 is the Assistance Listing Number for “Global Tuberculosis:Developing,Evaluating,Implementing Evidence-based and Innovative Approaches to Find, Cure, and Prevent Tuberculosis Globally.” Assistance Listing Numbers (formerly CFDA numbers) identify federal assistance programs; individual grant opportunities reference the listing they are funded under.
Who can apply under ALN 93.494?
The SAM.gov listing names these applicant types: Unrestricted by Entity Type. Each funding notice under the program sets its own eligibility, so check the specific opportunity.
How much funding does 93.494 provide?
The agency reported $5,082,733 in obligations for FY2025 in the SAM.gov Assistance Listing. These are program-wide totals reported by the agency, not a prediction of future awards.